SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.97 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $13,085,000 | +3.6% | 218,625 | -20.7% | 0.96% | -3.2% |
| Q1 2018 | $12,626,000 | +4.2% | 275,675 | -9.3% | 1.00% | +12.3% |
| Q4 2017 | $12,114,000 | -7.9% | 303,995 | -7.6% | 0.89% | 0.0% |
| Q3 2017 | $13,158,000 | -23.6% | 328,945 | -17.7% | 0.89% | -13.0% |
| Q2 2017 | $17,220,000 | +7727.3% | 399,540 | +4389.2% | 1.02% | +9181.8% |
| Q3 2016 | $220,000 | -42.3% | 8,900 | -52.4% | 0.01% | -42.1% |
| Q2 2016 | $381,000 | -10.8% | 18,700 | -33.2% | 0.02% | -5.0% |
| Q1 2016 | $427,000 | -90.4% | 28,000 | -91.5% | 0.02% | -89.2% |
| Q4 2015 | $4,440,000 | -9.5% | 330,380 | -5.5% | 0.18% | -8.0% |
| Q3 2015 | $4,904,000 | -36.9% | 349,510 | -23.7% | 0.20% | -29.0% |
| Q2 2015 | $7,776,000 | – | 457,970 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
| Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
| KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
| AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
| Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
| Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
| Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
| SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
| Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |